Product and Service [Axis]
Product Revenue [Member]
Grant Revenue [Member]
Class of Stock [Axis]
Convertible Preferred Stock [Member]
Equity Components [Axis]
Preferred Stock [Member]
Common Stock [Member]
Treasury Stock, Common [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Customer [Axis]
Customers [Member]
Concentration Risk Type [Axis]
Customer Concentration Risk [Member]
Concentration Risk Benchmark [Axis]
Revenue Benchmark [Member]
Three Customers [Member]
One Granting Agency [Member]
Two Customers [Member]
Accounts Receivable [Member]
Customers Together [Member]
Cash and Cash Equivalents [Axis]
Cash [Member]
US Treasury Securities [Member]
Fair Value Hierarchy and NAV [Axis]
Fair Value, Inputs, Level 2 [Member]
Measurement Frequency [Axis]
Fair Value, Recurring [Member]
Fair Value, Inputs, Level 1 [Member]
Fair Value, Inputs, Level 3 [Member]
Measurement Input Type [Axis]
Measurement Input, Share Price [Member]
Measurement Input Strike Price [Member]
Measurement Input, Price Volatility [Member]
Measurement Input, Risk Free Interest Rate [Member]
Measurement Input, Expected Term [Member]
Finite-Lived Intangible Assets by Major Class [Axis]
In Process Research and Development [Member]
Noncompete Agreements [Member]
Geographical [Axis]
UNITED STATES
Product [Member]
Grant [Member]
Rest of World [Member]
Geographic Concentration Risk [Member]
Warrant [Member]
Antidilutive Securities [Axis]
Restricted Stock Units (RSUs) [Member]
Plan Name [Axis]
2015 Long Term Incentive Plan [Member]
Award Type [Axis]
Share-Based Payment Arrangement, Option [Member]
Statement of Income Location, Balance [Axis]
Cost of Sales [Member]
Selling and Marketing Expense [Member]
General and Administrative Expense [Member]
Research and Development Expense [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
ATM Agreement [Member]
Legal Entity [Axis]
Piper Sandler & Co. [Member]
Statistical Measurement [Axis]
Maximum [Member]
Related and Nonrelated Parties [Axis]
CoSara Diagnostics Pvt Ltd [Member]
Cover [Abstract]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
Entity Listing, Par Value Per Share
Statement of Financial Position [Abstract]
Assets
Current assets
Cash and cash equivalents
Marketable investment securities
Accounts receivable, net
Inventory, net
Prepaid expenses and other current assets
Total current assets
Property and equipment, net
Operating lease right-of-use asset
Intangible assets, net
Investment in joint venture
Total assets
Liabilities and stockholders’ equity
Current liabilities
Accounts payable
Accrued expenses
Operating lease liability, current
Contingent consideration liabilities, current
Deferred revenue
Total current liabilities
Long-term liabilities
Income taxes payable
Operating lease liability
Contingent consideration liabilities
Total long-term liabilities
Total liabilities
Commitments and contingencies (Note 10)
Stockholders’ equity
Convertible preferred stock, $0.001 par value; 5,000,000 shares authorized; 0 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively
Common stock, $0.001 par value; 100,000,000 shares authorized; 38,421,321 shares issued and 33,572,643 shares outstanding as of March 31, 2025 and 37,902,222 shares issued and 33,053,544 shares outstanding as of December 31, 2024
Treasury stock, at cost; 4,848,678 shares held as of March 31, 2025 and December 31, 2024, respectively
Additional paid-in capital
Accumulated other comprehensive income
Accumulated deficit
Total stockholders’ equity
Total liabilities and stockholders’ equity
Convertible preferred stock, par value
Convertible preferred stock , shares authorized
Convertible preferred stock, shares issued
Convertible preferred stock, shares outstanding
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Treasury stock, shares
Statement [Table]
Statement [Line Items]
Total revenue
Cost of revenue
Gross profit
Operating expenses
Sales and marketing
General and administrative
Research and development
Depreciation and amortization
Total operating expenses
Loss from operations
Other income, net
Interest income, net
Realized gain on investments
Gain on remeasurement of acquisition contingencies
Loss on equity method investment in joint venture
Total other income, net
Loss before income taxes
Income tax provision
Net loss
Other comprehensive income (loss)
Change in net unrealized gains (losses) on marketable securities, net of tax
Total other comprehensive income (loss)
Comprehensive loss
Loss per common share:
Basic
Diluted
Weighted average shares outstanding:
Basic
Diluted
Statement of Cash Flows [Abstract]
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization
Stock-based compensation expense
Change in fair value of acquisition contingencies
Non-cash lease expense
Realized gain on investments
Loss from equity method investment
Provision for (recoveries of) credit losses
Inventory obsolescence expense (recovery)
Changes in assets and liabilities:
Accounts receivable
Prepaid expenses and other assets
Inventory
Deferred revenue
Income taxes payable
Accounts payable, accrued expenses and other liabilities
Net cash used in operating activities
Cash flows from investing activities
Purchases of property and equipment
Proceeds from maturities of marketable investment securities
Purchases of marketable securities
Net cash provided by investing activities
Cash flows from financing activities
Issuance of common stock related to at-the-market offering, net of offering costs
Net cash provided by financing activities
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental disclosure of cash flow information
Income taxes paid
Balance
Balance, shares
Issuance of common stock related to at-the-market offering, net of offering costs
Issuance of common stock related to at-the-market offering, net of offering costs, shares
Stock-based compensation
Stock-based compensation, shares
Other comprehensive income (loss), net of tax
Balance
Balance, shares
Accounting Policies [Abstract]
Overview and Basis of Presentation
Summary of Significant Accounting Policies
Cash and Cash Equivalents [Abstract]
Cash, Cash Equivalents, and Financial Instruments
Fair Value Disclosures [Abstract]
Fair Value Measurements
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets, Net
Revenue from Contract with Customer [Abstract]
Revenue
Earnings Per Share [Abstract]
Loss Per Share
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation
Income Tax Disclosure [Abstract]
Income Taxes
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies
Equity [Abstract]
Share Repurchase Program
At-the-market Agreement
At-the-Market Agreement
Related Party Transactions [Abstract]
Related Party Transactions
Reclassifications
Operating Segments
Accounts Receivable
Inventory
Revenue Recognition
Grant Revenue
Income Taxes
Concentrations Risk and Significant Customers
Recently Issued Accounting Standards
Schedule of Cash, Cash Equivalents and Marketable Investment Securities
Schedule of Fair Value Assets and Liabilities
Schedule of Changes in the Fair Value Measurement
Schedule of Contingent Consideration Common Stock and Warrants
Schedule of Intangible Assets, Net
Summary of Revenue by Geographic Area
Schedule of Deferred Revenue
Schedule of Basis and Diluted Earnings Per Share
Schedule of Option Activity
Schedule of Outstanding Restricted Stock Units and Related Party
Schedule of Warrant Activity
Schedule of Recognized Stock-Based Compensation Expense
Schedule of Lease Expense
Schedule of Maturities on Company Lease Liabilities
Schedule of Other Information Related to Operating Leases
Nature of Operation, Product Information, Concentration of Risk [Table]
Product Information [Line Items]
Accounts receivable
Doubtful accounts
Inventory
Inventory finished goods
Inventory raw materials
Inventory reserves
Grant funding revenue
Deferred revenue
Concentration risk percentage
Cash and Cash Equivalent [Table]
Cash and Cash Equivalents [Line Items]
Adjusted Cost
Total Unrealized Gains / (Losses)
Fair Value
Cash and Cash Equivalents
Marketable Securities
Fair Value, Recurring and Nonrecurring [Table]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents
Marketable securities (U.S. treasury bills and notes)
Total assets measured at fair value
Contingent consideration - common stock
Contingent consideration - warrants
Total liabilities measured at fair value
Fair value as of December 31, 2024
Change in fair value of contingent consideration issued for business acquisitions
Fair value as of March 31, 2025
Fair Value Measurement Inputs and Valuation Techniques [Table]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants measurement input
Expected term
Intangible Asset, Finite-Lived [Table]
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives in years, term
Intangible assets, gross
Less accumulated amortization
Disaggregation of Revenue [Table]
Disaggregation of Revenue [Line Items]
Revenue geographic area
Percentage of revenue
Deferred revenue, beginning balance
Revenue recognized included in deferred revenue balance
Increase due to prepayments from customers
Deferred revenue, ending balance
Net loss, as reported
Weighted average shares, basic
Dilutive effect of stock options, warrants and RSUs
Shares used to compute diluted loss per share
Basic loss per share
Diluted loss per share
Antidilutive Security, Excluded EPS Calculation [Table]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Securities excluded from computation of diluted earnings per share
Warrants to purchase shares of common stock
Number of Options Outstanding, Beginning
Weighted Average Exercise Price Outstanding, Beginning
Weighted Average Fair Value Outstanding, Beginning
Weighted-average Remaining Contractual Life (years) Outstanding, Beginning
Number of Options Outstanding, Granted
Weighted Average Exercise Price, Granted
Weighted Average Fair Value, Granted
Number of Options Outstanding, Expired
Weighted Average Exercise Price, Expired
Weighted Average Fair Value, Expired
Number of Options Outstanding, Forfeited/Cancelled
Weighted Average Exercise Price, Forfeited/Cancelled
Weighted Average Fair Value, Forfeited/Cancelled
Number of Options Outstanding, Exercised
Weighted Average Exercise Price, Exercised
Weighted Average Fair Value, Exercised
Number of Options Outstanding, Ending
Weighted Average Exercise Price Outstanding, Ending
Weighted Average Fair Value Outstanding, Ending
Number of Options Exercisable Ending
Weighted Average Exercise Price, Exercisable Ending
Weighted Average Fair Value, Exercisable Ending
Weighted-average Remaining Contractual Life (years), Exercisable Ending
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Restricted Stock Units, Outstanding Beginning
Weighted Average Grant Date Fair Value, Outstanding Beginning
Number of Restricted Stock Units, Granted
Weighted Average Grant Date Fair Value, Granted
Number of Restricted Stock Units, Vested
Weighted Average Grant Date Fair Value, Vested
Number of Restricted Stock Units, Forfeited/Cancelled
Weighted Average Grant Date Fair Value, Forfeited/Cancelled
Number of Restricted Stock Units, Outstanding Ending
Weighted Average Grant Date Fair Value, Outstanding Ending
Number of Warrants Outstanding, Beginning
Weighted Average Exercise Price, Beginning
Weighted Average fair value, Beginning
Weighted-average Remaining Contractual Life (Years) Outstanding
Number of Warrants Outstanding, Granted
Weighted Average Exercise Price, Granted
Weighted Average Fair Value, Granted
Number of Warrants Outstanding, Expired
Weighted Average Exercise Price, Expired
Weighted Average Fair Value, Expired
Number of Warrants Outstanding, Forfeited/Cancelled
Weighted Average Exercise Price, Forfeited/Cancelled
Weighted Average Fair Value, Forfeited/Cancelled
Number of Warrants Outstanding, Exercised
Weighted Average Exercise Price, Exercised
Weighted Average Fair Value, Exercised
Number of Warrants Outstanding, Ending
Weighted Average Exercise Price, Ending
Weighted Average Fair Value, Ending
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense
Number of common shares available for issuance
Aggregate intrinsic value of outstanding options
Unrecognized stock-based compensation
Stock based compensation expense related to weighted average period
Warrants exercisable
Warrants to purchase a common stock
Income tax expense (benefit)
Effective income tax rate reconciliation, percent
Effective income tax rate reconciliation, percent
Operating lease costs
Short-term lease costs
Total lease costs
2025 (remainder)
2026
2027
2028
Total lease payments
Less: imputed interest
Present value of operating lease liabilities
Less: current portion
Long-term portion
Cash paid for operating leases included in operating cash flows
Remaining lease term of operating leases
Discount rate of operating leases
Stock repurchase program authorized amount
Stock repurchased during period, shares
Issuance of common stock offering price
Sale of stock, number of shares issued in transaction
Net proceeds from issuance of common stock
Gross proceeds from issuance of equity
Related Party Transaction [Table]
Related Party Transaction [Line Items]
Research and development expenses
Taxes payable non current.
Gain on remeasurement of acquisition contingencies.
Noncash lease expense.
Grant Revenue [Policy Text Block]
Grant Funding Revenue.
Customers [Member]
Three Customers [Member]
One Granting Agency [Member]
Two Customers [Member]
Customers Together [Member]
Fair value of contingent consideration to common stock.
Fair value of contigent consideration to warrants.
Contingent considered issued for business acquisitions.
Measurement Input Strike Price [Member]
Indefinite lived intangible asset useful life.
Rest of World [Member]
Increase due to prepayments from customers.
Share based compensation arrangement by share based payment award options non vested weighted average grant date fair value exercised.
Share based compensation arrangement by share based payment award options non vested weighted average grant date fair value exercisable.
Weighted average exercise price, beginning.
Weighted average exercise price granted.
Sharebased compensation arrangements by sharebased payment award nonoptions expired in period weighted average exercise price.
Weighted average exercise price, forfeited/cancelled.
Sharebased compensation arrangements by sharebased payment award nonoptions exercised in period weighted average exercise price.
Weighted average price at which grantees can acquire the shares reserved for issuance under the non-option plan.
Share based compensation arrangement by share based payment award non options outstanding weighted average fair value.
Weighted average grant date fair value, granted
Share based compensation arrangement by share based payment award options non vested weighted average grant date fair value exercised.
Sharebased compensation arrangements by sharebased payment award options nonvested nonoptions forfeitures weighted average grant date fair value.
Sharebased compensation arrangements by sharebased payment award options nonvested nonoptions exercised weighted average grant date fair value.
Weighted average fair value, beginning.
Weighted-average remaining contractual life (years) outstanding, beginning.
Class of warrant exercisable.
Schedule of Operating Lease [Table Text Block]
The entire disclosure for at-the-market agreement.
ATM Agreement [Member]
Piper Sandler & Co. [Member]
CoSara Diagnostics Pvt Ltd [Member]
Product Revenue [Member]
Grant Revenue [Member]
2015 Long Term Incentive Plan [Member]
Assets, Current
Assets [Default Label]
Liabilities, Current
Liabilities, Noncurrent
Liabilities
Treasury Stock, Value
Equity, Attributable to Parent
Liabilities and Equity
Gross Profit
Operating Expenses
Operating Income (Loss)
Nonoperating Income (Expense)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Other Comprehensive Income (Loss), before Tax
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Depreciation, Depletion and Amortization
Increase (Decrease) in Accounts Receivable
Increase (Decrease) in Prepaid Expense
Increase (Decrease) in Inventories
Increase (Decrease) in Contract with Customer, Liability
Increase (Decrease) in Income Taxes Payable
Net Cash Provided by (Used in) Operating Activities
Payments to Acquire Property, Plant, and Equipment
Payments to Acquire Marketable Securities
Net Cash Provided by (Used in) Investing Activities
Net Cash Provided by (Used in) Financing Activities
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations
Shares, Outstanding
Income Tax, Policy [Policy Text Block]
Deferred Revenue
Business Combination, Contingent Consideration, Liability, Noncurrent
Contract with Customer, Liability
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueExercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageFairValue
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantedInPeriodWeightedAverageExercisePrice
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNonOptionsGrantedWeightedAverageGrantDateFairValue
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExpiredInPeriodWeightedAverageExercisePrice
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNonOptionsExpirationsWeightedAverageGrantDateFairValue
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNonOptionsForfeituresWeightedAverageGrantDateFairValue
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNonOptionsExercisedWeightedAverageGrantDateFairValue
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonOutstandingWeightedAverageExercisePrice
SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsWeightedAverageGrantDateFairValue
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent
Lease, Cost
Lessee, Operating Lease, Liability, to be Paid